Influence of the preparation method on the physicochemical properties of econazole-β-cyclodextrin complexes

被引:24
作者
Al-Marzouqi, Ali H. [1 ]
Solieman, Ayser [1 ]
Shehadi, Ihsan [2 ]
Adem, Abdu [3 ]
机构
[1] United Arab Emirates Univ, Dept Chem & Petr Engn, Al Ain, U Arab Emirates
[2] United Arab Emirates Univ, Dept Chem, Al Ain, U Arab Emirates
[3] United Arab Emirates Univ, Dept Pharmacol & Therapeut, Al Ain, U Arab Emirates
关键词
cyclodextrin; econazole; inclusion complex; supercritical carbon dioxide;
D O I
10.1007/s10847-007-9356-6
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
Econazole (C18H15Cl3N2O) is one of the common antifungal agents whose poor aqueous solubility restricts its use for the treatment of oropharyngeal candidiasis, which is the first symptom of HIV infection. Therefore, the aim of the current study was to investigate the effect of different preparation methods (i.e. kneading, coevaporation, sealed-heating, and supercritical carbon dioxide (SC CO2)) for obtaining solid inclusion complexes between beta-cyclodextrin and econazole. The physico-chemical properties of the different products were characterized by differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR) and powder X-ray diffractometry (PXRD). For the complexes prepared by the SC CO2 method, the effects of temperature and pressure have also been investigated and related to the solubility of econazole in SC CO2. Results suggested the validity of the SC CO2 method for preparing solid complexes between cyclodextrins and econazole, avoiding the use of organic solvents and problems of their complete removal. Moreover, temperature played a major role in promoting drug-carrier interactions, whereas pressure had limited effects.
引用
收藏
页码:85 / 93
页数:9
相关论文
共 35 条
[1]
Phase solubility and inclusion complex of itraconazole with β-cyclodextrin using supercritical carbon dioxide [J].
Al-Marzouqi, AH ;
Shehatta, I ;
Jobe, B ;
Dowaidar, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (02) :292-304
[2]
Physicochemical characterization of drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques [J].
Al-Marzouqi, Ali ;
Jobe, Baboucarr ;
Corti, Giovanna ;
Cirri, Marzia ;
Mura, Paola .
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2007, 57 (1-4) :223-231
[3]
Evaluation of supercritical fluid technology as preparative technique of benzocaine-cyclodextrin complexes - Comparison with conventional methods [J].
Al-Marzouqi, Ali H. ;
Jobe, Baboucarr ;
Dowaidar, Ali ;
Maestrelli, Francesca ;
Mura, Paola .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 43 (02) :566-574
[4]
Preparation of budesonide- and indomethacin-hydroxypropyl-β-cyclodextrin (HPBCD) complexes using a single-step, organic-solvent-free supercritical fluid process [J].
Bandi, N ;
Wei, W ;
Roberts, CB ;
Kotra, LP ;
Kompella, UB .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 23 (02) :159-168
[5]
Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl-β-cyclodextrin [J].
Charoenchaitrakool, M ;
Dehghani, F ;
Foster, NR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 239 (1-2) :103-112
[6]
Oropharyngeal and esophageal candidiasis in immunocompromised patients: Treatment issues [J].
Darouiche, RO .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (02) :259-272
[7]
Enhancement of bioavailability of griseofulvin by its complexation with β-cyclodextrin [J].
Dhanaraju, MD ;
Kumaran, KS ;
Baskaran, T ;
Moorthy, MSR .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1998, 24 (06) :583-587
[8]
DUCHENE D, 1990, PHARM TECHNOL, P22
[9]
FABING I, 2000, Patent No. 2815540
[10]
Itraconazole formation using supercritical carbon dioxide [J].
Hassan, A ;
Tang, YM ;
Ayres, JW .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2004, 30 (10) :1029-1035